Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 74301-74350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05866536
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
PHASE2Recruiting
100 participants
Started: May 4, 2023 · Completed: May 31, 2028
4 conditions1 sponsor1 location
NCT05799066
Measuring Relative Afferent Pupillary Defect
NAActive, not recruiting
71 participants
Started: May 4, 2023 · Completed: May 14, 2026
1 condition2 sponsors1 location
NCT05726487
Physical Activity Intervention for Black Women With Asthma
NARecruiting
224 participants
Started: May 4, 2023 · Completed: Jun 3, 2026
1 condition3 sponsors2 locations
NCT06034288
Xeomin vs Botox for Treatment of Overactive Bladder Syndrome
PHASE2Recruiting
64 participants
Started: May 4, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05698316
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
N/AActive, not recruiting
1,000 participants
Started: May 4, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors25 locations
NCT05894369
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
N/ARecruiting
10 participants
Started: May 4, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05841186
Correlation of Timing of Pegfilgrastim Administration and PIBP.
NARecruiting
156 participants
Started: May 4, 2023 · Completed: May 31, 2025
6 conditions1 sponsor1 location
NCT05824520
Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy
NANot yet recruiting
1,066 participants
Started: May 4, 2023 · Completed: May 20, 2026
2 conditions1 sponsor1 location
NCT06302738
Phenotypisation of Sleep Pattern in Hypertensive Patients With Non Dipper Pattern
N/ARecruiting
143 participants
Started: May 4, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor11 locations
NCT05541250
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
PHASE1Recruiting
30 participants
Started: May 4, 2023 · Completed: Sep 29, 2026
1 condition2 sponsors1 location
NCT05716516
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
PHASE2Recruiting
36 participants
Started: May 4, 2023 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05740462
Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest)
NAEnrolling by invitation
52 participants
Started: May 4, 2023 · Completed: Sep 1, 2025
2 conditions2 sponsors1 location
NCT03608280
Efficiency of 3D-printed Implant Versus Autograft for Orbital Reconstruction (TOR-3D)
NARecruiting
92 participants
Started: May 4, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05661578
A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors
PHASE2Active, not recruiting
60 participants
Started: May 4, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor38 locations
NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
PHASE1Active, not recruiting
5 participants
Started: May 4, 2023 · Completed: May 4, 2028
19 conditions1 sponsor7 locations
NCT06905119
Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
NARecruiting
201 participants
Started: May 4, 2023 · Completed: Jul 31, 2026
23 conditions2 sponsors1 location
NCT06115317
Homonymous Hemianopia in Childhood
NAEnrolling by invitation
25 participants
Started: May 4, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05894746
Gfree - For Improved Blood Sugar and Reduced Inflammation.
NARecruiting
60 participants
Started: May 4, 2023 · Completed: Dec 31, 2030
4 conditions4 sponsors2 locations
NCT05808504
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
NARecruiting
90 participants
Started: May 3, 2023 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT05639569
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
N/ARecruiting
145 participants
Started: May 3, 2023 · Completed: Dec 30, 2030
2 conditions1 sponsor8 locations
NCT05002660
The Change Club Study: Evaluation of Civic Engagement for Built Environment Change and Health Improvement
NAActive, not recruiting
2,420 participants
Started: May 3, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors13 locations
NCT05755854
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
PHASE1Recruiting
10 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06380140
Relationship Between Acute Phase Markers and Post-operative Pain in Open Tension-free Inguinal Hernia Repair: An Observational Study
N/ARecruiting
71 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05733715
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
EARLY_PHASE1Recruiting
30 participants
Started: May 3, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT06070974
ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE Study
N/ARecruiting
100 participants
Started: May 3, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT05890092
Vulvar Disease in Nigeria Observational Study
N/ARecruiting
1,000 participants
Started: May 3, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor1 location
NCT05831176
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
PHASE2Active, not recruiting
22 participants
Started: May 3, 2023 · Completed: Nov 25, 2026
4 conditions2 sponsors53 locations
NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
PHASE4Recruiting
200 participants
Started: May 3, 2023 · Completed: Sep 22, 2026
2 conditions2 sponsors1 location
NCT05743673
SHAPE Test for Preoperative Risk Stratification
N/ARecruiting
200 participants
Started: May 3, 2023 · Completed: May 29, 2026
2 conditions1 sponsor1 location
NCT05671562
The Effect of Lycopene on Sperm Quality in Men Attending Fertility Clinic
NAActive, not recruiting
80 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05876754
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
PHASE3Recruiting
220 participants
Started: May 3, 2023 · Completed: Jun 1, 2025
1 condition1 sponsor78 locations
NCT05794022
Cohort of STEMI Patients 2
NARecruiting
300 participants
Started: May 3, 2023 · Completed: Jun 3, 2031
1 condition1 sponsor2 locations
NCT06954636
Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
N/ARecruiting
128 participants
Started: May 3, 2023 · Completed: Dec 31, 2028
3 conditions2 sponsors2 locations
NCT05918328
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
PHASE2Recruiting
610 participants
Started: May 3, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04883255
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_PHASE1Recruiting
138 participants
Started: May 3, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05782361
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
PHASE1Recruiting
19 participants
Started: May 3, 2023 · Completed: Jan 9, 2029
2 conditions3 sponsors4 locations
NCT05721209
Virtual Reality Treadmill Training in Individuals with Traumatic Brain Injury
NARecruiting
20 participants
Started: May 3, 2023 · Completed: Dec 23, 2025
1 condition1 sponsor1 location
NCT05094908
Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
PHASE1Active, not recruiting
16 participants
Started: May 3, 2023 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05592015
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
PHASE2Recruiting
28 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06851988
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
NARecruiting
180 participants
Started: May 3, 2023 · Completed: Oct 30, 2027
3 conditions1 sponsor1 location
NCT05627635
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
20 participants
Started: May 3, 2023 · Completed: Oct 7, 2025
7 conditions2 sponsors1 location
NCT05880342
The Role of the Brain in Mental and Physical Fatigue
PHASE3Recruiting
62 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05890131
Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy
NAActive, not recruiting
5,996 participants
Started: May 3, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor5 locations
NCT05483465
The Effect of NAD Supplementation on Brain Vascular Health in Aging
PHASE4Recruiting
214 participants
Started: May 3, 2023 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT06871657
Comparing Two Surgical Techniques for Building Up the Bone Where a Dental Implant is to Be Placed
N/ARecruiting
30 participants
Started: May 3, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05755711
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
N/AActive, not recruiting
399 participants
Started: May 3, 2023 · Completed: Apr 30, 2028
1 condition1 sponsor49 locations
NCT06745999
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
PHASE4Recruiting
40 participants
Started: May 3, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05562349
Clavulanic Acid for the Treatment of Cocaine Use Disorder
PHASE2Active, not recruiting
65 participants
Started: May 3, 2023 · Completed: Jul 31, 2024
1 condition4 sponsors2 locations
NCT05797506
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
PHASE2Active, not recruiting
100 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT05831865
Frontline of ASCT in High-risk DLBCL
N/ARecruiting
175 participants
Started: May 3, 2023 · Completed: Apr 27, 2027
1 condition2 sponsors1 location